
ADMA
ADMA Biologics Inc
$17.26
-$0.12(-0.69%)
61
Overall
60
Value
63
Tech
--
Quality
Market Cap
$4.08B
Volume
2.53M
52W Range
$13.50 - $25.67
Target Price
$32.33
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $7.2M | $10.7M | $22.8M | $17.0M | $29.3M | $42.2M | $80.9M | $154.1M | $258.2M | $426.5M | ||
Total Revenue | $7.1M | $10.5M | $22.8M | $17.0M | $29.3M | $42.2M | $80.9M | $154.1M | $258.2M | $426.5M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-4.3M | $-6.4M | $-29.2M | $-42.2M | $39.5M | $61.3M | $79.8M | $118.8M | $169.3M | $206.9M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $2.9M | $4.3M | $-6.4M | $-25.2M | $-10.2M | $-19.1M | $1.2M | $35.3M | $88.9M | $219.6M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-22.7M | $-28.0M | $-62.1M | $-77.3M | $31.3M | $45.8M | $59.5M | $74.6M | $67.3M | $80.6M | ||
Research & Development | $7.0M | $7.7M | $5.6M | $3.9M | $2.3M | $5.9M | $3.6M | $3.6M | $3.3M | $1.8M | ||
Research Expense | $7.0M | $7.7M | $5.6M | $3.9M | $2.3M | $5.9M | $3.6M | $3.6M | $3.3M | $1.8M | ||
Selling, General & Administrative | $6.7M | $8.5M | $18.8M | $22.5M | $25.9M | $35.1M | $42.9M | $52.5M | $59.0M | $74.1M | ||
Selling & Marketing Expenses | -- | $-200.0K | $-600.0K | $-800.0K | $-1.0M | $1.1M | $1.4M | $2.2M | $3.3M | $2.7M | ||
General & Administrative Expenses | $6.7M | $8.5M | $18.8M | $22.5M | $25.9M | $35.1M | $42.9M | $52.5M | $59.0M | $74.1M | ||
Salaries & Wages | $-1.7M | $-1.3M | $-1.6M | $-2.2M | $-2.7M | $2.9M | $3.5M | -- | -- | -- | ||
Depreciation & Amortization | $-469.8K | $-469.6K | $1.2M | $844.9K | $844.9K | $715.4K | $715.4K | $700.0K | $700.0K | $400.0K | ||
Depreciation & Amortization | $-469.8K | $-469.6K | $1.2M | $844.9K | $844.9K | $715.4K | $715.4K | $700.0K | $700.0K | $400.0K | ||
Amortization | -- | -- | $1.2M | $844.9K | $844.9K | $715.4K | $715.4K | $700.0K | $700.0K | $400.0K | ||
Other Operating Expenses | $4.6M | $5.4M | $6.5M | $7.8M | $2.2M | $4.2M | $12.3M | $17.8M | $4.3M | $4.2M | ||
OPERATING INCOME | ||||||||||||
Operating income | $-15.5M | $-17.3M | $-38.5M | $-60.3M | $-41.4M | $-64.9M | $-58.4M | $-39.4M | $21.6M | $139.0M | ||
EBITDA | $-15.4M | $-17.8M | $-39.4M | $-60.2M | $-45.3M | $-59.8M | $-53.1M | $-39.0M | $6.8M | $148.5M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $1.8M | $2.2M | $3.3M | $5.5M | $9.0M | $12.0M | $13.1M | $19.3M | $25.0M | $13.9M | ||
Intinc | $37.8K | $50.3K | $57.2K | $195.4K | $12.3M | $288.1K | $34.5K | $45.0K | $1.6M | $2.1M | ||
Net Non-Operating Interest Income/Expense | $-1.8M | $-2.2M | $-3.2M | $-5.3M | $3.3M | $-11.7M | $-92.8M | $19.2M | $-23.4M | $-11.8M | ||
Gain on Sale of Securities | $67.9K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Other Income/Expense | $651.2K | $-4.5K | $1.2M | $127.1K | $10.2M | $-863.3K | $251.6K | $-7.3M | $26.5M | $1.4M | ||
Other Special Charges | $-719.1K | $4.5K | $-1.2M | $-127.1K | $-10.2M | $863.3K | $-251.6K | $-7.3M | $-26.5M | $-1.4M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | $83.0M | $52.9M | -- | -- | -- | -- | -- | -- | -- | ||
Special Income Charges | -- | $-83.0M | $-845.4K | -- | -- | -- | -- | $-3.0M | $-3.8M | -- | ||
Impairment of Capital Assets | -- | -- | $845.4K | -- | -- | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-16.1M | $-18.8M | $-42.8M | $-64.6M | $-49.6M | $-63.8M | $-58.6M | $-48.4M | $-4.0M | $139.6M | ||
Pre-Tax Income | $-18.0M | $-19.5M | $-43.8M | $-65.7M | $-48.3M | $-75.7M | $-71.6M | $-65.9M | $-28.2M | $125.7M | ||
INCOME TAX | ||||||||||||
Tax Provision | $-602.4K | $-1.5M | $-17.3M | $-104.4K | $-474.2K | $-3.8M | $-251.8K | $-1.8M | $-763.0K | $-72.0M | ||
NET INCOME | ||||||||||||
Net Income | $-18.0M | $-19.5M | $-43.8M | $-65.7M | $-48.3M | $-75.7M | $-71.6M | $-65.9M | $-28.2M | $197.7M | ||
Net Income (Continuing Operations) | $-18.0M | $-19.5M | $-43.8M | $-65.7M | $-48.3M | $-75.7M | $-71.6M | $-65.9M | $-28.2M | $197.7M | ||
Net Income (Discontinued Operations) | $-18.0M | $-19.5M | $-43.8M | $-65.7M | $-48.3M | $-75.7M | $-71.6M | $-65.9M | $-28.2M | $197.7M | ||
Net Income (Common Stockholders) | $-18.0M | $-19.5M | $-43.8M | $-65.7M | $-48.3M | $-75.7M | $-71.6M | $-65.9M | $-28.2M | $197.7M | ||
TOTALS | ||||||||||||
Total Expenses | $-27.0M | $-34.4M | $-91.2M | $-119.5M | $70.8M | $107.1M | $139.3M | $193.4M | $236.6M | $287.5M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $10.4M | $12.2M | $22.9M | $45.2M | $54.3M | $86.1M | $139.6M | $197.9M | $224.0M | $233.1M | ||
Average Shares Outstanding (Diluted) | $10.4M | $12.1M | $22.9M | $45.3M | $54.3M | $86.1M | $139.6M | $197.9M | $224.0M | $243.3M | ||
Shares Outstanding | $10.7M | $12.9M | $45.3M | $46.4M | $86.3M | $121.3M | $195.9M | $222.2M | $228.2M | $237.6M | ||
Basic EPS | -- | -- | $-1.17 | -- | -- | $-0.88 | $-0.51 | $-0.33 | $-0.13 | $0.85 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.88 | $-0.51 | $-0.33 | $-0.13 | $0.85 | ||
Diluted EPS | $-1.73 | $-1.61 | $-1.91 | $-1.45 | $-0.89 | $-0.88 | $-0.51 | $-0.33 | $-0.13 | $0.81 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-0.89 | -- | $-0.51 | $-0.33 | $-0.13 | $0.81 | ||
OTHER METRICS | ||||||||||||
Allowances For Construction | -- | -- | -- | -- | -- | -- | $79.8M | -- | -- | -- | ||
Gain On Sale Of P P E | -- | -- | -- | -- | $207.1K | $81.7K | -- | -- | -- | -- | ||
Interest Expense Operating | -- | $-1.5M | $-2.3M | $-4.4M | $-10.3M | $-10.3M | $-11.2M | -- | -- | -- | ||
Marketing Expense | -- | $-200.0K | $-600.0K | $-800.0K | $-1.0M | $1.1M | $1.4M | -- | -- | -- | ||
Other Gand A | $6.7M | $8.5M | $18.8M | $22.5M | $25.9M | $35.1M | $42.9M | $52.5M | $59.0M | $74.1M | ||
Other Write Down | -- | -- | -- | -- | -- | $61.3M | -- | -- | -- | -- | ||
Rent And Landing Fees | $6.7M | $8.5M | $18.8M | $22.5M | $-600.0K | $700.0K | -- | -- | -- | -- | ||
Restruct | -- | $83.0M | $52.9M | -- | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ADMA | $17.26 | -0.7% | 2.53M |
3 | ||||
4 | ||||
5 | ||||
6 |